Abstract
The epidermal growth factor receptor (EGFR) and its homologs ErbB3 and ErbB4 adopt a tethered conformation in the absence of ligand in which an extended hairpin loop from domain II contacts the juxtamembrane region of domain IV and tethers the domain I/II pair to the domain III/IV pair. By burying the hairpin loop, which is required for formation of active receptor dimers, the tether contact was thought to prevent constitutive activation of EGFR and its homologs. Amino-acid substitutions at key sites within the tether contact region fail to result in constitutively active receptors however. We report here the 2.5 Å crystal structure of the N-terminal three extracellular domains of ErbB4, which bind ligand but lack domain IV and thus the tether contact. This ErbB4 fragment nonetheless adopts a domain arrangement very similar to the arrangement adopted in the presence of the tether suggesting that regions in addition to the tether contribute to maintaining this conformation and inactivity in the absence of the tether contact. We suggest that the tether conformation may have evolved to prevent crosstalk between different EGFR homologs and thus allow diversification of EGFR and its homologs.
Keywords: ErbB4, EGFR, autoinhibition, structure
Introduction
The human epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, also known as ErbBs or HERs, consists of four members: EGFR (ErbB1/HER1), ErbB2 (HER2), ErbB3 (HER3), and ErbB4 (HER4).1, 2 Each ErbB is essential for normal development in the mouse,3 and abnormal activity of each ErbB has been associated with human cancer.4–6 EGFR and ErbB2 in particular have been associated with increased cancer severity, and monoclonal antibodies and small-molecule kinase inhibitors targeting EGFR and ErbB2 are approved cancer therapies.7
ErbB extracellular regions are composed of four domains arranged as a tandem array of two Large domain/Cysteine-rich (L/CR) domain pairs, termed domains I (L1), II (CR1), III (L2), and IV (CR2) beginning with the N-terminal L domain.2 Ligands bind to ErbB extracellular regions at binding sites composed of regions from domains I and III and stabilize a specific receptor dimer in which the intracellular kinase activity is stimulated.2, 8, 9 Crystal structures of the extracellular regions of EGFR, ErbB3, and ErbB4 revealed that in the absence of ligand a ∼25 Å β-hairpin loop extends from domain II to contact the juxtamembrane region of domain IV.2, 10–12 This contact constrains the extracellular region into a folded-over or “tethered” conformation in which ligand-binding sites on domains I and III are too far apart to bind ligand simultaneously. When ligand binds, the domain II/IV contact is broken and the domain I/II pair undergoes a ∼130° rotation to juxtapose domains I and III and compose a complete binding site.2, 8, 9 In the ligand-bound conformation, the hairpin loop on domain II is exposed and mediates interreceptor signaling dimers. The role of the tethered conformation of EGFR, ErbB3, and ErbB4 thus appeared to be sequestering the domain II loop, now also known as the “dimerization arm,” and preventing formation of active receptor dimers in the absence of ligand.2
Mutagenesis of the tether-binding pocket on domain IV failed to result in constitutive activation of EGFR, however, and the importance of the tether for maintaining ErbBs in an inactive state was questioned.13, 14 Subsequent SAXS studies of the EGFR extracellular region showed that mutation of the tether pocket failed to convert it from a compact conformation to the extended conformation that is observed when ligand is bound,15 suggesting that elements outside of the tether play a role in stabilizing the tethered conformation. To address this issue, we determined and report here the crystal structure of a fragment of the ErbB4 extracellular region encompassing the N-terminal three domains (tErbB4). This fragment contains all ligand-binding elements but lacks domain IV, which is necessary to constitute the tether interaction. Consistent with the SAXS results, this structure shows that tErbB4 adopts a tethered-like domain arrangement similar to the structure of the ErbB4 extracellular region in the absence of ligand.10 A recent structure of a comparable fragment of ErbB3 also exhibits a tethered-like structure indicating this conformation is a general feature of ErbBs in the absence of the tether contact.16
Results and Discussion
A fragment of the extracellular region of human ErbB4 encompassing domains I, II, and III (tErbB4; residues 1–497) was expressed in Lec1 cells with an N-terminal human growth hormone/hexahistidine tag that was removed before crystallization,17, 18 purified as described for a 4-domain fragment of ErbB4,10 crystallized by the hanging-drop vapor diffusion method using a 1:1 mixture of a 4 mg/mL protein solution and crystallization buffer (16% PEG 8000, 0.2M calcium acetate and 0.1M sodium cacodylate pH 6.0), and its 2.5 Å structure determined by molecular replacement using sErbB4 domains as search models (Fig. 1). Data collection and refinement statistics are shown in Table I. The structure reveals that tErbB4 retains a tethered-like domain arrangement in the absence of the domain IV tether pocket (Fig. 2). Domain III in tErbB4 is shifted relative to the domain I/II pair ∼28° about an axis perpendicular to the long axis of domain II when compared with its relative orientation in the 4-domain sErbB4 structure (Fig. 2). When ligand is bound to EGFR, domain III undergoes an additional ∼90° rotation about an axis parallel to the long axis of domain II relative to its conformation in unliganded receptor. The presence of a tethered-like conformation in a similarly truncated form of ErbB316 suggests that lattice interactions are not responsible for this conformation and that structural elements in the domain II/III hinge region, which is the only contact region between domain III and the domain I/II pair in tErbB4, stabilize the tethered conformation in the absence of the tether contact itself. This observation may explain in part the absence of constitutive activity in EGFR variants with mutations in the tether pocket.13, 14 Also of note is the similar arrangement of domains I, II, and III of the type I insulin-like growth factor receptor (IGF1R), which are homologous to the corresponding ErbB domains.19 A 17° rotation will superimpose domain III of IGF1R on domain III of tErbB4 following initial superposition of the domain I/II pairs, which suggests that the domain II/III hinge relationship is stabilized in different receptor classes. A partially activating mutation in the domain II/III hinge region in the C. elegans EGFR homolog LET-23,20 which is unlikely to adopt the tethered conformation,21 further suggests that this hinge region conformation stabilizes an inactive conformation.
Figure 1.

The tErbB4 structure. Stereo pair of an alpha carbon trace of the tErbB4 structure. Every twentieth residue is indicated with a sphere and the domain II tether hairpin, specfic domains, and unobscured residue spheres are labeled.
Table I.
Data Collection and Refinement Statistics
| Data collection | |
| Wavelength (Å) | 1.54 |
| Space group | P212121 |
| Unit cell dimensions | |
| a (Å) | 42.2 |
| b (Å) | 85.6 |
| c (Å) | 152.4 |
| Resolution (Å) | 25–2.57 |
| No. of unique reflections | 17809 |
| Completeness (%) | 97.1 (97.2) |
| I/σ | 17.1 (3.1) |
| Rmerge (last shell) (%) | 8.9 (47.2) |
| Redundancy (last shell) | 5.2 (4.6) |
| Refinement | |
| Rwork (%) | 19.2 |
| Rfree (%) | 24.3 |
| No. of atoms | |
| Protein | 3737 |
| Water | 86 |
| Sugar | 70 |
| rmsd | |
| Bond length (Å) | 0.01 |
| Bond angle (°) | 1.24 |
| Ramachandran plot (%) | |
| Most favored | 85.5 |
| Additional allowed | 13.5 |
| Generously allowed | 0.2 |
| Disallowed | 0.7 |
| Average B-values (Å2) | |
| Protein | 50.1 |
| Water | 39.4 |
Figure 2.

Comparison of tErbB4 with liganded and unliganded ErbB structures. Orthogonal views of worm diagrams of tErbB4 (red), sErbB4 (yellow), and sEGFR when complexed with TGFα (slate blue) following superposition of the domain I/II pairs.
The question then arises of what, if any, functional role is played by the tether contact. A possible answer to this question is suggested by the recent crystal structures of the extracellular region of the Drosophila EGFR in the presence and absence of ligand.21, 22 Only one EGFR homolog is present in the Drosophila genome, and these structures revealed an untethered structure for Drosophila EGFR in the absence of ligand.21 When ligand is bound a ∼20° relative shift of domains I and III occurs22; this shift is also apparent in human EGFR when ligand binds and has been characterized as a shift from “straight” to “bent” conformations of domain II.23 The Drosophila EGFR structures also reveal an asymmetric receptor dimer when ligand is bound as one receptor subunit remains in the unliganded conformation.21 If the Drosophila EGFR activation mechanism is the precursor of the vertebrate ErbB activation mechanism, the participation of an unliganded receptor in an active signaling complex suggests that the tether may have evolved to prevent crosstalk between homologous receptors following duplication of ErbB genes. ErbBs bind different subsets of ligands, activate different collections of downstream effectors, and mediate distinct but overlapping biological effects.1, 3, 24 Such separate biological functions would have been difficult to evolve if unliganded ErbB receptors were free to participate in active signaling complexes with all other ErbBs regardless of ligand. The tether thus appears to have facilitated evolution of functional diversity among ErbBs.
PDB Coordinates
Atomic coordinates and structure factors have been deposited in the PDB and assigned accession code 3U2P.
References
- 1.Burgess AW. EGFR family: structure physiology signalling and therapeutic targets. Growth Factors. 2008;26:263–274. doi: 10.1080/08977190802312844. [DOI] [PubMed] [Google Scholar]
- 2.Burgess AW, et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell. 2003;12:541–552. doi: 10.1016/s1097-2765(03)00350-2. [DOI] [PubMed] [Google Scholar]
- 3.Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000;19:3159–3167. doi: 10.1093/emboj/19.13.3159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Rudloff U, Samuels Y. A growing family: adding mutated Erbb4 as a novel cancer target. Cell Cycle. 2010;9:1487–1503. doi: 10.4161/cc.9.8.11239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Holbro T, Hynes NE. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol. 2004;44:195–217. doi: 10.1146/annurev.pharmtox.44.101802.121440. [DOI] [PubMed] [Google Scholar]
- 6.Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer progression. Exp Cell Res. 2003;284:99–110. doi: 10.1016/s0014-4827(02)00099-x. [DOI] [PubMed] [Google Scholar]
- 7.Johnston JB, et al. Targeting the EGFR pathway for cancer therapy. Curr Med Chem. 2006;13:3483–3492. doi: 10.2174/092986706779026174. [DOI] [PubMed] [Google Scholar]
- 8.Garrett TP, et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell. 2002;110:763–773. doi: 10.1016/s0092-8674(02)00940-6. [DOI] [PubMed] [Google Scholar]
- 9.Ogiso H, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 2002;110:775–787. doi: 10.1016/s0092-8674(02)00963-7. [DOI] [PubMed] [Google Scholar]
- 10.Bouyain S, Longo PA, Li S, Ferguson KM, Leahy DJ. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc Natl Acad Sci USA. 2005;102:15024–15029. doi: 10.1073/pnas.0507591102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ferguson KM, et al. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell. 2003;11:507–517. doi: 10.1016/s1097-2765(03)00047-9. [DOI] [PubMed] [Google Scholar]
- 12.Cho HS, Leahy DJ. Structure of the extracellular region of HER3 reveals an interdomain tether. Science. 2002;297:1330–1333. doi: 10.1126/science.1074611. [DOI] [PubMed] [Google Scholar]
- 13.Mattoon D, Klein P, Lemmon MA, Lax I, Schlessinger J. The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function. Proc Natl Acad Sci USA. 2004;101:923–928. doi: 10.1073/pnas.0307286101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Walker F, et al. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. J Biol Chem. 2004;279:22387–22398. doi: 10.1074/jbc.M401244200. [DOI] [PubMed] [Google Scholar]
- 15.Dawson JP, Bu Z, Lemmon MA. Ligand-induced structural transitions in ErbB receptor extracellular domains. Structure. 2007;15:942–954. doi: 10.1016/j.str.2007.06.013. [DOI] [PubMed] [Google Scholar]
- 16.Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, Totpal K, Wong A, Lee CV, Stawicki, Clark R, Fields C, Lewis Phillips GD, Prell RA, Danilenko DM, Franke Y, Stephan JP, Hwang J, Wu Y, Bostrom J Sliwkowski MX, Fuh G, Eigenbrot C. A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared to monospecific antibodies. Cancer Cell. 2011;18:472–486. doi: 10.1016/j.ccr.2011.09.003. [DOI] [PubMed] [Google Scholar]
- 17.Stanley P. Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity. Mol Cell Biol. 1989;9:377–383. doi: 10.1128/mcb.9.2.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Leahy DJ, Dann CE, Longo P, Perman B, Ramyar KX. A mammalian expression vector for expression and purification of secreted proteins for structural studies. Protein Expr Purif. 2000;20:500–506. doi: 10.1006/prep.2000.1331. [DOI] [PubMed] [Google Scholar]
- 19.Garrett TP, McKern NM, Lou M, Frenkel MJ, Bentley JD, Lovrecz GO, Elleman TC, Cosgrove LJ, Ward CW. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature. 1998;394:395–399. doi: 10.1038/28668. [DOI] [PubMed] [Google Scholar]
- 20.Moghal N, Sternberg PW. Extracellular domain determinants of LET-23 (EGF) receptor tyrosine kinase activity in Caenorhabditis elegans. Oncogene. 2003;22:5471–5480. doi: 10.1038/sj.onc.1206648. [DOI] [PubMed] [Google Scholar]
- 21.Alvarado D, Klein DE, Lemmon MA. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. Nature. 2009;461:287–291. doi: 10.1038/nature08297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Alvarado D, Klein DE, Lemmon MA. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell. 2010;142:568–579. doi: 10.1016/j.cell.2010.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lemmon MA. Ligand-induced ErbB receptor dimerization. Exp Cell Res. 2009;315:638–648. doi: 10.1016/j.yexcr.2008.10.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127–137. doi: 10.1038/35052073. [DOI] [PubMed] [Google Scholar]
